Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Valemetostat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Sankyo’s Ezharmia Receives Japanese Approval For T-Cell Lymphoma
    Daiichi Sankyo’s Ezharmia Receives Japanese Approval For T-Cell Lymphoma

    25 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169939&sid=2

    PHARMABIZ
    25 Jun 2024
    Share Share
    Ezharima launched in Japan as first dual EZH1 and EZH2 inhibitor therapy
    Ezharima launched in Japan as first dual EZH1 and EZH2 inhibitor therapy

    20 Dec 2022

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/ezharima-launched-in-japan-as-first-dual-ezh1-and-ezh2-inhibitor-therapy-for-leukemialymphoma-13478

    INDIANPHARMAPOST
    20 Dec 2022
    Share Share
    Valemetostat NDA Submitted in Japan for Adult T-Cell Leukemia/Lymphoma
    Valemetostat NDA Submitted in Japan for Adult T-Cell Leukemia/Lymphoma

    28 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211222005563/en

    BUSINESSWIRE
    28 Dec 2021
    Share Share
    Valemetostat Pivotal Data Shows Promising Response Rates in ATL
    Valemetostat Pivotal Data Shows Promising Response Rates in ATL

    11 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211211005008/en

    BUSINESSWIRE
    11 Dec 2021
    Share Share
    Valemetostat Data at EHA Shows Promising Durable Tumor Response
    Valemetostat Data at EHA Shows Promising Durable Tumor Response

    11 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210611005034/en

    BUSINESSWIRE
    11 Jun 2021
    Share Share
    Valemetostat Data at EHA Shows Promising Durable Tumor Response
    Valemetostat Data at EHA Shows Promising Durable Tumor Response

    11 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210611005034/en

    BUSINESSWIRE
    11 Jun 2021
    Share Share